Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive SummaryPMA-supplement guidance
You may also be interested in...
The move is in line with the agency’s intention to focus on the total product life-cycle, such that the same staffers that review an original marketing submission will look at the safety and effectiveness of manufacturing changes.
Radiological health post-market offices moving to OIVD. FDA issues global engagement report. More regulatory news.